Financial statements Bio-Tech
Balance sheet of Bio-Tech
Company age:
Age:
24 y. 1 m. 16 d.
Share capital:
Share capital:
224 000 PLN
Balance sheet data of BIO-TECH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 18 738 122,38 | 16 722 942,08 | 18 737 288,91 | 13 959 468,42 | 15 793 870,38 |
| A. Fixed assets | 1 234 807,62 | 1 951 617,55 | 1 271 138,46 | 1 600 153,18 | 1 849 421,22 |
| B. Current assets | 17 503 314,76 | 14 771 324,53 | 17 466 150,45 | 12 359 315,24 | 13 944 449,16 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 18 738 122,38 | 16 722 942,08 | 18 737 288,91 | 13 959 468,42 | 15 793 870,38 |
| A. Equity | 13 833 055,18 | 10 485 844,26 | 10 192 106,58 | 7 215 521,04 | 7 299 634,36 |
| B. Liabilities and provisions for liabilities | 4 905 067,20 | 6 237 097,82 | 8 545 182,33 | 6 743 947,38 | 8 494 236,02 |
| I. Long-term liabilities | 0,00 | 0,00 | 314 208,50 | 209 472,36 | 0,00 |
| II. Short-term liabilities | 2 958 732,83 | 2 197 461,43 | 2 899 815,61 | 2 073 089,02 | 3 183 452,79 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.